Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Sep 23 2025
Oct 4 2025
Sep 9 2025
Sep 3 2026
Apr 22 2026